Determinants of Overall and Progression-Free Survival of Nigerian Patients with Philadelphia-Positive Chronic Myeloid Leukemia

Objective. The tyrosine kinase inhibitors have markedly changed the disease course for patients with Ph+ and/or BCR-ABL1+ chronic myeloid leukemia (CML). This study was embarked upon to assess the long-term effects of imatinib therapy on survival in adult Nigerian patients with CML. Methods. All adu...

Full description

Saved in:
Bibliographic Details
Main Authors: Anthony A. Oyekunle, Rahman A. Bolarinwa, Adesola T. Oyelese, Lateef Salawu, Muheez A. Durosinmi
Format: Article
Language:English
Published: Wiley 2015-01-01
Series:Advances in Hematology
Online Access:http://dx.doi.org/10.1155/2015/908708
Tags: Add Tag
No Tags, Be the first to tag this record!